Cipla’s arm acquires 26% stake in AMPIN Energy C&I Eighteen

30 May 2025 Evaluate

Cipla’s subsidiary -- Jay Precision Pharmaceuticals has completed acquisition of 26% stake in AMPIN Energy C&I Eighteen on May 28, 2025. This is in line with the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a ‘captive user’ under Indian electricity laws.

Earlier, Jay Precision Pharmaceuticals had entered into Share Purchase, Subscription and Shareholder’s Agreement (SPSSA) to acquire 26% stake on a fully diluted basis in AMPIN Energy C&I Eighteen, for setting up captive solar power project in Maharashtra.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1501.00 0.90 (0.06%)
02-Jan-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.40
Dr. Reddys Lab 1240.70
Cipla 1501.00
Zydus Lifesciences 913.15
Lupin 2103.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×